XML 150 R136.htm IDEA: XBRL DOCUMENT v3.19.1
Note 26 - Parent Company Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Amortization of debt issuance costs $ 48 $ 45 $ 40
Provision for depreciation and amortization 1,738 2,061 1,908
(Increase) decrease in other assets (10) 863 118
Increase (decrease) in other liabilities 1,094 (961) 306
Net cash provided by operating activities 20,732 13,631 11,884
Cash flows from investing activities:      
Purchase of premises and equipment (351) (584) (2,873)
Net cash used by investing activities (63,559) (136,484) 31,212
Cash dividends paid on common stock (2,274) (1,776) (1,603)
Proceeds from stock options exercised 216 245 10
Net proceeds from issuance of common stock 26,778
Net cash provided by (used in) financing activities 23,222 121,416 (25,881)
Net increase (decrease) in cash and cash equivalents (19,605) (1,437) 17,215
Stock issued under employee plans 45 41
Vested and granted restricted stock issued under employee plans 84
Parent Company [Member]      
Net income 15,730 7,344 5,259
Equity in undistributed net income of subsidiaries (14,916) (7,340) (3,066)
Amortization of debt issuance costs 49 44 40
Provision for depreciation and amortization 22 6
(Increase) decrease in other assets 69 32 6
Increase (decrease) in other liabilities 227 59 (137)
Net cash provided by operating activities 1,181 145 2,102
Cash flows from investing activities:      
Purchase of premises and equipment (80) (82)
Net cash used by investing activities (80) (82)
Repayment of term debt (3,602) (1,819) (1,001)
Cash dividends paid on common stock (2,274) (1,776) (1,603)
Proceeds from stock options exercised 216 245 10
Net proceeds from issuance of common stock 26,778
Net cash provided by (used in) financing activities (5,660) 23,428 (2,594)
Net increase (decrease) in cash and cash equivalents (4,559) 23,491 (492)
Cash and cash equivalents at the beginning of year 23,984 493 985
Cash and cash equivalents at the end of year 19,425 23,984 493
Stock issued under employee plans 45 41
Vested and granted restricted stock issued under employee plans $ 84